Turim 21 Investimentos’s DexCom DXCM Stock Holding History

Turim 21 Investimentos’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-24	Closed	-$2K	–	119
2021 Q1	$2K	Buy	+24	New	+$2.25K	﹤0.01%	81

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Turim 21 Investimentos's DXCM Position: Q2 2021 in Review

Turim 21 Investimentos sold out of DexCom (DXCM) in Q2 2021, closing a stake of 24 shares — an estimated $2K sold.

Turim 21 Investimentos first reported a position in DXCM in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 726 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

Turim 21 Investimentos reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
Turim 21 Investimentos sold 24 DexCom shares in Q2 2021, an estimated $2K.
Turim 21 Investimentos first reported a position in DexCom in Q1 2021 and held it in 1 quarter.
Turim 21 Investimentos's DexCom position peaked at $2K in Q1 2021.
726 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on Turim 21 Investimentos's 13F filing for Q2 2021, filed 13 Aug 2021.